当前位置:首页 - 行情中心 - 派林生物(000403) - 财务分析

派林生物

(000403)

  

流通市值:192.68亿  总市值:205.32亿
流通股本:6.88亿   总股本:7.33亿

派林生物(000403)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润3.26亿元,每股收益0.45元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益712925.96万元,未分配利润154808.87万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产824460.92万元,负债111534.96万元。

利润表
报告期2023-09-302023-06-302023-03-312022-12-31
营业总收入1,374,813,312.16709,071,800.34260,860,262.392,405,188,425.37
营业总成本1,033,269,820.34572,349,333.11218,309,593.811,753,334,080.51
营业利润372,635,563.9161,363,516.7663,173,481.12663,429,496.09
利润总额370,068,990.92159,329,317.4162,916,890.35660,392,139.13
净利润325,813,319.79143,000,998.9456,218,316.92587,690,140.23
其他综合收益20,987.3525,570.44-9,140.3135,642.15
综合收益总额325,834,307.14143,026,569.3856,209,176.61587,725,782.38
资产负债表
报告期2023-09-302023-06-302023-03-312022-12-31
流动资产合计3,072,354,748.783,034,930,803.352,985,750,503.883,046,975,789.6
非流动资产合计5,172,254,458.45,052,359,803.194,940,080,224.254,935,348,676.17
资产总计8,244,609,207.188,087,290,606.547,925,830,728.137,982,324,465.77
流动负债合计844,740,272.45910,522,704.23798,269,241.41959,308,895.94
非流动负债合计270,609,346.77244,065,037.82202,481,287.63161,888,333.71
负债合计1,115,349,619.221,154,587,742.051,000,750,529.041,121,197,229.65
归属于母公司股东权益合计7,135,337,662.826,938,535,011.96,930,934,944.536,867,524,210.96
股东权益合计7,129,259,587.966,932,702,864.496,925,080,199.096,861,127,236.12
负债和股东权益合计8,244,609,207.188,087,290,606.547,925,830,728.137,982,324,465.77
现金流量表
报告期2023-09-302023-06-302023-03-312022-12-31
经营活动现金流入小计1,652,733,408.581,031,931,079.86562,858,056.372,095,263,801.91
经营活动现金流出小计1,427,000,210.4875,546,656.74456,293,328.811,571,044,938.48
经营活动产生的现金流量净额225,733,198.18156,384,423.12106,564,727.56524,218,863.43
投资活动现金流入小计529,327,122.16320,219,113.11130,123,766.01447,663,963
投资活动现金流出小计1,002,038,970.4657,525,425.33301,793,113.451,004,040,955.65
投资活动产生的现金流量净额-472,711,848.24-337,306,312.22-171,669,347.44-556,376,992.65
筹资活动现金流入小计386,892,834.67279,833,022.62121,451,368.08484,301,009.89
筹资活动现金流出小计358,440,681209,986,924.0583,351,929.69335,840,885.41
筹资活动产生的现金流量净额28,452,153.6769,846,098.5738,099,438.39148,460,124.48
汇率变动对现金及现金等价物的影响64,616.4778,428.73-27,896.72-1,189,516.09
现金及现金等价物净增加额-218,461,879.92-110,997,361.8-27,033,078.21115,112,479.17
期末现金及现金等价物余额782,073,629.21889,273,147.33973,237,430.921,000,270,509.13
TOP↑